Ian Hagemann, Md, PhD

Academic Department Pathology and Immunology
Research Program Solid Tumor Therapeutics
Ian Hagemann

Researcher Background

Primary Academic Title

Professor, Department of Pathology and Immunology, WashU Medicine

Training

  • 2008 - 2011: Resident in Anatomic Pathology, Hospital of the University of Pennsylvania, Philadelphia, PA
  • 2010 - 2011: Chief Resident, Anatomic Pathology , Hospital of the University of Pennsylvania, Philadelphia, PA
  • 2011 - 2012: Fellow in Selective (Surgical) Pathology, Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO
  • 2012 - 2013: Fellow in Molecular Genetic Pathology, Washington University, St. Louis, MO

Education

  • 2008: MD, Washington University School of Medicine, St. Louis, MO
  • 2008: PhD, Washington University School of Medicine, St. Louis, MO

Research & Select Publications

Research Interest

Clinical and translational research on the gentic and epigenetic basis of gynecologic cancers

Research publications

Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial.
Authors:

Kong T, Mabry A, Highkin M, one or more additional authors omitted Hagemann IS, one or more additional authors omitted Ma CX

Journal & Year:

Nat Commun • 2026

Molecular Characterization of Patients with Metastatic Invasive Lobular Carcinoma: Using Real-World Data to Describe This Unique Clinical Entity.
Authors:

Davis AA, Jaeger E, Hagemann IS, one or more additional authors omitted Cristofanilli M

Journal & Year:

Clin Cancer Res • 2025

Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancer.
Authors:

Schab A, Compadre A, Drexler R, one or more additional authors omitted Hagemann IS, one or more additional authors omitted Mullen MM

Journal & Year:

J Clin Invest • 2025

Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients.
Authors:

Zhang X, Goedegebuure SP, Chen MY, one or more additional authors omitted Hagemann IS, one or more additional authors omitted Gillanders WE

Journal & Year:

Genome Med • 2024

Tumour evolution and microenvironment interactions in 2D and 3D space.
Authors:

Mo CK, Liu J, Chen S, one or more additional authors omitted Hagemann IS, one or more additional authors omitted Ding L

Journal & Year:

Nature • 2024